Brisbane attracts world’s leading Head and Neck Cancer Congress
The World Congress of the International Federation of Head and Neck Oncologic Societies (IFHNOS) will take place at the Brisbane Convention & Exhibition Centre in 2026, with the aim of raising the global benchmark for the care and treatment of patients with head and neck cancer.
Professor Sandro Porceddu, Director, Radiation Oncology Research at Brisbane’s Princess Alexandra Hospital and BCEC Advocate, led the winning bid against a highly competitive field of international destinations from Europe, the Middle East and Asia.
Professor Porceddu said the decision to choose Brisbane as the host city at the recent 2018 IFHNOS World Congress in Buenos Aires in September was unanimous. Pivotal to the decision, he said, was the strong support of the city’s key convention partners together with the world class facilities of the Brisbane Convention & Exhibition Centre and its successful hosting of the 2014 G20 Summit.
The Congress is expected to attract some of the world’s most eminent surgeons, oncologists, scientists, researchers and allied health workers in the field of head and neck cancer, with Professor Porceddu saying it “will cement Brisbane and Queensland as a major cancer research hub”.
“Key factors in selecting Brisbane as the host city are its world leading institutions and great minds in cancer research, including being home of the Gardasil vaccine for cervical cancer,” he said.
“In the head and neck space globally, our strengths lie in the development of immunotherapy and vaccines and having a world class health system providing the very best cancer care.”